Oncology

  1. Beleodaq (belinostat)
    Beleodaq (belinostat)
    by Spectrum Pharmaceuticals, Inc.
    for Lymphoma
    €3,336.00
  2. Besponsa (inotuzumab ozogamicin)
    Besponsa (inotuzumab ozogamicin)
    by Pfizer Limited
    for Leukemia
    €12,283.22
  3. Blincyto (blinatumomab)
    Blincyto (blinatumomab)
    by Amgen
    for Leukemia
    €2,520.00
  4. Cabometyx (cabozantinib)
    Cabometyx (cabozantinib)
    by Ipsen Pharma
    for Kidney Cancer
    €6,552.00
  5. Cometriq (cabozantinib)
    Cometriq (cabozantinib)
    by Ipsen Pharma
    for Thyroid Cancer
    €5,113.50
  6. Cotellic (cobimetinib)
    Cotellic (cobimetinib)
    by Roche Registration GmbH
    for Skin Cancer
    €5,223.75
  7. Darzalex (daratumumab)
    Darzalex (daratumumab)
    by Janssen-Cilag International N.V.
    for Multiple Myeloma
    €576.00
  8. Empliciti (elotuzumab)
    Empliciti (elotuzumab)
    by Bristol-Myers Squibb
    for Multiple Myeloma
    €1,137.29
  9. Ibrance (palbociclib)
    Ibrance (palbociclib)
    by Pfizer Limited
    for Breast Cancer
    €2,520.00
View as Grid List

Items 10-18 of 35

per page
Set Descending Direction